Sh Pharma (02607) announced that, after obtaining the recommended advice from the Audit Committee of the Board of Directors, the Board of Directors held a meeting on December 21, 2023 to review and approve the Proposal on Changing the Accounting Firm for the Year 2024, recommending the appointment of Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) as the audit agency for the company's 2024 financial statements and internal control audits. However, this proposal needs to be approved by the shareholders at the shareholder's annual meeting to take effect.
Zhixin Finance APP News, Shanghai Pharmaceutical Industry (02607) issued an announcement that, after obtaining the recommended advice from the Audit Committee of the Board of Directors, the Board of Directors held a meeting on December 21, 2023 to review and approve the Proposal on Changing the Accounting Firm for the Year 2024, recommending the appointment of Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) as the audit agency for the company's 2024 financial statements and internal control audits. However, this proposal needs to be approved by the shareholders at the shareholder's annual meeting to take effect.